Member news

Molecular Health to present at upcoming congresses

More at molecularhealth.com…

MagForce AG to host Lunch Symposium on Local Therapies in Malignant Gliomas during the 19th European Congress of Neurosurgery (EANS2019)

More at magforce.com…

Immunic, Inc. Doses First Healthy Volunteer in its Phase 1 Clinical Program of IMU-935, a Potentially Best-in-Class RORγt Inverse Agonist

More at immunic-therapeutics.com…

CTI Announces Addition of Scott Batty, MD as VP, Global Regulatory and Scientific Affairs

More at ctifacts.com…

MorphoSys's Licensee Janssen Submits Biologics License Application to U.S. FDA of Tremfya(R) (Guselkumab) for Treatment of Adults with Active Psoriatic Arthritis

More at morphosys.com…

Eurofins announces the success of its Tender Offer on its 300M€ outstanding hybrid notes with a first call date on 31 January 2020

More at eurofins.com…